223 related articles for article (PubMed ID: 26720913)
1. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
Poynter JN; Richardson M; Blair CK; Roesler MA; Hirsch BA; Nguyen P; Cioc A; Warlick E; Cerhan JR; Ross JA
Cancer Epidemiol; 2016 Feb; 40():134-40. PubMed ID: 26720913
[TBL] [Abstract][Full Text] [Related]
2. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
[TBL] [Abstract][Full Text] [Related]
3. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
[TBL] [Abstract][Full Text] [Related]
5. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
Kaplan H; Malmgren J; De Roos AJ
Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
[TBL] [Abstract][Full Text] [Related]
6. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.
Kristinsson SY; Björkholm M; Hultcrantz M; Derolf ÅR; Landgren O; Goldin LR
J Clin Oncol; 2011 Jul; 29(21):2897-903. PubMed ID: 21690473
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis.
Schnatter AR; Glass DC; Tang G; Irons RD; Rushton L
J Natl Cancer Inst; 2012 Nov; 104(22):1724-37. PubMed ID: 23111193
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
Khan N; Patel D; Trivedi C; Kavani H; Pernes T; Medvedeva E; Lewis J; Xie D; Yang YX
Am J Gastroenterol; 2021 Apr; 116(4):741-747. PubMed ID: 33982944
[TBL] [Abstract][Full Text] [Related]
9. Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: a prospective study and meta-analysis.
Teras LR; Patel AV; Carter BD; Rees-Punia E; McCullough ML; Gapstur SM
Br J Haematol; 2019 Jul; 186(2):243-254. PubMed ID: 30977126
[TBL] [Abstract][Full Text] [Related]
10. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB
Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278
[TBL] [Abstract][Full Text] [Related]
11. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.
Kaplan HG; Malmgren JA; Li CI; Calip GS
Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034
[TBL] [Abstract][Full Text] [Related]
12. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.
Rollison DE; Shain KH; Lee JH; Hampras SS; Fulp W; Fisher K; Al Ali NH; Padron E; Lancet J; Xu Q; Olesnyckyj M; Kenvin L; Knight R; Dalton W; List A; Komrokji RS
Cancer Med; 2016 Jul; 5(7):1694-701. PubMed ID: 27098006
[TBL] [Abstract][Full Text] [Related]
13. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
Jonsdottir G; Björkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Aug; 107(2):275-282. PubMed ID: 33966293
[TBL] [Abstract][Full Text] [Related]
14. Higher body mass index in 16-19 year-old Jewish Adolescents of North African, Middle Eastern and European Origins is a Predictor of Acute Myeloid Leukemia: a cohort of 2.3 million Israelis.
Shamriz O; Leiba M; Levine H; Derazne E; Keinan-Boker L; Kark JD
Cancer Causes Control; 2017 Apr; 28(4):331-339. PubMed ID: 28258513
[TBL] [Abstract][Full Text] [Related]
15. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005.
Kaplan HG; Malmgren JA; Atwood MK
BMC Cancer; 2011 Jun; 11():260. PubMed ID: 21693006
[TBL] [Abstract][Full Text] [Related]
16. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
Björkholm M; Derolf AR; Hultcrantz M; Kristinsson SY; Ekstrand C; Goldin LR; Andreasson B; Birgegård G; Linder O; Malm C; Markevärn B; Nilsson L; Samuelsson J; Granath F; Landgren O
J Clin Oncol; 2011 Jun; 29(17):2410-5. PubMed ID: 21537037
[TBL] [Abstract][Full Text] [Related]
17. Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes.
Goldin LR; Kristinsson SY; Liang XS; Derolf AR; Landgren O; Björkholm M
J Clin Oncol; 2012 Jan; 30(2):179-83. PubMed ID: 22162584
[TBL] [Abstract][Full Text] [Related]
18. Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.
Linabery AM; Roesler MA; Richardson M; Warlick ED; Nguyen PL; Cioc AM; Poynter JN
Cancer Epidemiol; 2022 Feb; 76():102090. PubMed ID: 34995873
[TBL] [Abstract][Full Text] [Related]
19. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
Li D; Morris JS; Liu J; Hassan MM; Day RS; Bondy ML; Abbruzzese JL
JAMA; 2009 Jun; 301(24):2553-62. PubMed ID: 19549972
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
